SWI5

Across TCGA pan-cancer cohorts, SWI5 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SWI5 data layer compared with 28 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher SWI5 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SWI5 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

COAD, LUAD, and BLCA are the cancer types where SWI5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.401	0.811	<.001	31	view →
LUAD	DFS	Median	All	0.229	0.813	<.001	10	view →
BLCA	DFS	Median	III,IV	1.000	0.539	.037	3	view →
LUSC	OS	Median	All	0.196	0.724	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

SWI5–COAD (OS)

Open the COAD breakdown →